Spero Therapeutics, Inc.
SPRO
Revenue
114.00k
▼-26.00k▼-18.57%
3 Months ChangeAssets
149.88M
▼-17.82M▼-10.63%
3 Months ChangeLiabilities
69.38M
▼-2.07M▼-2.90%
3 Months ChangeFree Cash Flow
-23.41M
▼-12.40M▼-112.70%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 8-K
ID: 0001193125-24-246627
2024-09-10
Form 8-K
ID: 0001193125-24-216310
2024-08-05
Form 10-Q
ID: 0000950170-24-090782
2024-08-05
Form 8-K
ID: 0001193125-24-193913
2024-06-03
Form 8-K
ID: 0001193125-24-153034
2024-05-15
Form 8-K
ID: 0001193125-24-139364
2024-05-15
Form 10-Q
ID: 0000950170-24-060400
2024-03-29
Form 8-K
ID: 0001193125-24-082060
2024-03-13
Form 8-K
ID: 0001193125-24-066825
2024-02-09
Form 8-K
ID: 0001193125-24-029913